Travere Therapeutics, Inc. TVTX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s intangibles (net)?
- Travere Therapeutics, Inc. (TVTX) reported intangibles (net) of $110.04M in Q1 2026.
- How has Travere Therapeutics, Inc.'s intangibles (net) changed year-over-year?
- Travere Therapeutics, Inc.'s intangibles (net) increased by 6.0% year-over-year, from $103.82M to $110.04M.
- What is the long-term trend for Travere Therapeutics, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s intangibles (net) has grown at a -5.9% compound annual growth rate (CAGR), from $154.13M to $113.87M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.